HeartWare

HeartWare International Inc (NASDAQ: HTWR), a developer of medical devices, confirmed on Wednesday it has received notice from Engaged Capital, an activist hedge fund and shareholder, which nominated 3 director candidates to the company's Board of Directors. Engaged Capital has made its...

Wunderlich Securities initiated its coverage of Thoratec (NASDAQ: THOR) with a Hold. At the same time, Wunderlich has set its price target on the company's stock to $35. In a research report published today, Wunderlich stressed that Thoratec's dominant market position might be in danger from fierce...

Today, Wedbush has raised its HeartWare (NASDAQ: HTWR) PT To $80.